Inhibrx Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Inhibrx Biosciences, Inc.‘s stocks are currently a part of 53 hedge funds’ portfolios, which represents 27.29% of the total amount of its stocks outstanding. This makes up a total of 10.94M shares of Inhibrx Biosciences, Inc.. Compared to the previous quarter, the number fell by -69.62% or -25.08M shares fewer. As for the holding position changes, 37.74% (20) of current hedge fund investors increased the number of shares held, 35.85% (19) of current holders sold a part of the shares held, and 20.75% (11) closed the holdings completely. 4 hedge funds are new holders of Inhibrx Biosciences, Inc. stock in Q1 2023, it is 7.55% of total holders.
Hedge funds holding Inhibrx Biosciences (Q3 2020 – Q1 2023)
| Q3 2020 | 32 |
|---|---|
| Q4 2020 | 51 |
| Q1 2021 | 55 |
| Q2 2021 | 61 |
| Q3 2021 | 66 |
| Q4 2021 | 100 |
| Q1 2022 | 96 |
| Q2 2022 | 97 |
| Q3 2022 | 100 |
| Q4 2022 | 114 |
| Q1 2023 | 53 |
Hedge funds changes in Inhibrx Biosciences positions (Q3 2020 – Q1 2023)
| Q3 2020 | 32 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2020 | 29 | 10 | 7 | 10 | -5 |
| Q1 2021 | 9 | 24 | 12 | 5 | 5 |
| Q2 2021 | 14 | 28 | 8 | 8 | 3 |
| Q3 2021 | 9 | 25 | 18 | 4 | 10 |
| Q4 2021 | 38 | 26 | 24 | 4 | 8 |
| Q1 2022 | 15 | 40 | 27 | 19 | -5 |
| Q2 2022 | 17 | 40 | 24 | 13 | 3 |
| Q3 2022 | 13 | 46 | 27 | 10 | 4 |
| Q4 2022 | 24 | 51 | 31 | 9 | -1 |
| Q1 2023 | 4 | 20 | 19 | 11 | -1 |
Hedge funds changes in Inhibrx Biosciences stock options (Q3 2020 – Q1 2023)
| Q3 2020 | 0 | 0 |
|---|---|---|
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 5,197,000 | 0 |
| Q1 2022 | 2,929,000 | 2,000 |
| Q2 2022 | 245,000 | 1,000 |
| Q3 2022 | 369,000 | 12,656,000 |
| Q4 2022 | 680,064 | 3,301,240 |
| Q1 2023 | 235,875,000 | 1,000 |